Miconnet I - Search Results

1

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.

Valmori D, Lévy F, Miconnet I, Zajac P, Spagnoli GC, Rimoldi D, Liénard D, Cerundolo V, Cerottini JC, Romero P. Valmori D, et al. Among authors: miconnet i. J Immunol. 2000 Jan 15;164(2):1125-31. doi: 10.4049/jimmunol.164.2.1125. J Immunol. 2000. PMID: 10623865

2

CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.

Miconnet I, Koenig S, Speiser D, Krieg A, Guillaume P, Cerottini JC, Romero P. Miconnet I, et al. J Immunol. 2002 Feb 1;168(3):1212-8. doi: 10.4049/jimmunol.168.3.1212. J Immunol. 2002. PMID: 11801657

3

Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.

Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini JC, Romero P. Men Y, et al. Among authors: miconnet i. J Immunol. 1999 Mar 15;162(6):3566-73. J Immunol. 1999. PMID: 10092815

4

Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction.

Miconnet I, Coste I, Beermann F, Haeuw JF, Cerottini JC, Bonnefoy JY, Romero P, Renno T. Miconnet I, et al. J Immunol. 2001 Apr 1;166(7):4612-9. doi: 10.4049/jimmunol.166.7.4612. J Immunol. 2001. PMID: 11254719

5

Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen.

Wirth S, Bille F, Koenig S, Wehrli N, Miconnet I, Lévy F, Diggelmann H, Romero P, Acha-Orbea H. Wirth S, et al. Among authors: miconnet i. Int J Cancer. 2002 May 10;99(2):201-6. doi: 10.1002/ijc.10237. Int J Cancer. 2002. PMID: 11979434

6

Amino acid identity and/or position determines the proteasomal cleavage of the HLA-A*0201-restricted peptide tumor antigen MAGE-3271-279.

Miconnet I, Servis C, Cerottini JC, Romero P, Lévy F. Miconnet I, et al. J Biol Chem. 2000 Sep 1;275(35):26892-7. doi: 10.1074/jbc.M000701200. J Biol Chem. 2000. PMID: 10859301 Free article.

7

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

Esslinger C, Chapatte L, Finke D, Miconnet I, Guillaume P, Lévy F, MacDonald HR. Esslinger C, et al. Among authors: miconnet i. J Clin Invest. 2003 Jun;111(11):1673-81. doi: 10.1172/JCI17098. J Clin Invest. 2003. PMID: 12782670 Free PMC article.

8

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway.

Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry JP, Delneste Y, Herbault N, Baussant T, Magistrelli G, Soulas C, Romero P, Cerottini JC, Bonnefoy JY. Jeannin P, et al. Among authors: miconnet i. Nat Immunol. 2000 Dec;1(6):502-9. doi: 10.1038/82751. Nat Immunol. 2000. PMID: 11101872

9

Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure.

Miconnet I, Marrau A, Farina A, Taffé P, Vigano S, Harari A, Pantaleo G. Miconnet I, et al. J Immunol. 2011 Jun 15;186(12):7039-49. doi: 10.4049/jimmunol.1003309. Epub 2011 May 9. J Immunol. 2011. PMID: 21555537 Free article.

10

STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.

Alves PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, Gross DA, Miconnet I, Chouaib S, Fizazi K, Soria JC, Lemonnier FA, Kosmatopoulos K. Alves PM, et al. Among authors: miconnet i. Cancer Immunol Immunother. 2006 Dec;55(12):1515-23. doi: 10.1007/s00262-006-0165-3. Epub 2006 Apr 19. Cancer Immunol Immunother. 2006. PMID: 16622681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters